X4 Pharmaceuticals (XFOR) Misses Q4 EPS by 22c
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.22). Revenue for the quarter came in at $2.57 million.
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.22). Revenue for the quarter came in at $2.57 million.
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.